印度农村精神卫生保健支持:一项整群随机临床试验
该平行整群随机对照试验在印度哈里亚纳邦和安得拉邦3个区44个农村初级卫生中心开展,纳入9928名成人,评估包含数字精神卫生干预与社区反污名活动的多层面干预。12个月时高危组平均PHQ-9评分干预组低于对照组(2.77 vs 4.48),但两组合并的行为评分无差异。
要点
- 高危组12个月平均PHQ-9评分干预组2.77 vs 对照组4.48,平均差-1.71(95%CI -2.53至-0.89;P<.001)。
- 高危组缓解率干预组74.7% vs 对照组50.6%(OR 2.88;95%CI 1.53至5.42;P=.001)。
- 两组合并12个月行为评分干预组17.39 vs 对照组17.74,平均差-0.35(95%CI -1.11至0.41;P=.36),无差异。
核心结论
- 多层面干预可有效降低抑郁风险,但未改善精神疾病求助行为意向。
研究设计与样本
- 平行、整群随机、常规照护对照试验,2020年9月至2021年12月在印度哈里亚纳邦和安得拉邦3个区44个农村初级卫生中心开展,随访评估在3、6、12个月进行且评估者设盲。
- 共招募9928名成人(高危3365名、非高危6563名;女性5638名[57%]、男性4290名[43%];平均[SD]年龄43[16]岁),12个月随访9057名(91.2%)。
- 高危定义为PHQ-9评分≥10分、GAD-7评分≥10分或PHQ-9自伤/自杀风险条目评分≥2分。
- 12个月干预包括面向所有参与者的社区反污名活动和仅面向高危参与者的数字精神卫生干预,初级卫生保健工作者接受世界卫生组织精神卫生差距行动规划指南培训以识别和管理高危参与者。
- 数据清理与分析时间为2022年4月至2023年2月。
主要发现
- 高危组12个月平均PHQ-9评分干预组2.77 vs 对照组4.48,平均差-1.71(95%CI -2.53至-0.89;P<.001)。
- 高危组缓解率(PHQ-9和GAD-7评分<5且无自伤风险)干预组74.7% vs 对照组50.6%(OR 2.88;95%CI 1.53至5.42;P=.001)。
- 两组合并12个月行为评分(精神卫生知识、态度和行为量表)干预组17.39 vs 对照组17.74,平均差-0.35(95%CI -1.11至0.41;P=.36),无差异。
关键数值与推荐
- 高危组12个月平均PHQ-9评分干预组2.77 vs 对照组4.48,平均差-1.71(95%CI -2.53至-0.89;P<.001)。
- 高危组缓解率干预组74.7% vs 对照组50.6%(OR 2.88;95%CI 1.53至5.42;P=.001)。
- 两组合并12个月行为评分干预组17.39 vs 对照组17.74,平均差-0.35(95%CI -1.11至0.41;P=.36)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: More than 150 million people in India need mental health care but few have access to affordable care, especially in rural areas. OBJECTIVE: To determine whether a multifaceted intervention involving a digital health care model along with a community-based antistigma campaign leads to reduced depression risk and lower mental health-related stigma among adults residing in rural India. DESIGN, SETTING, AND PARTICIPANTS: This parallel, cluster randomized, usual care-controlled trial was conducted from September 2020 to December 2021 with blinded follow-up assessments at 3, 6, and 12 months at 44 rural primary health centers across 3 districts in Haryana and Andhra Pradesh states in India. Adults aged 18 years and older at high risk of depression or self-harm defined by either a Patient Health Questionnaire-9 item (PHQ-9) score of 10 or greater, a Generalized Anxiety Disorder-7 item (GAD-7) score of 10 or greater, or a score of 2 or greater on the self-harm/suicide risk question on the PHQ-9. A second cohort of adults not at high risk were selected randomly from the remaining screened population. Data were cleaned and analyzed from April 2022 to February 2023. INTERVENTIONS: The 12-month intervention included a community-based antistigma campaign involving all participants and a digital mental health intervention involving only participants at high risk. Primary health care workers were trained to identify and manage participants at high risk using the Mental Health Gap Action Programme guidelines from the World Health Organization. MAIN OUTCOMES AND MEASURES: The 2 coprimary outcomes assessed at 12 months were mean PHQ-9 scores in the high-risk cohort and mean behavior scores in the combined high-risk and non-high-risk cohorts using the Mental Health Knowledge, Attitude, and Behavior scale. RESULTS: Altogether, 9928 participants were recruited (3365 at high risk and 6563 not at high risk; 5638 [57%] female and 4290 [43%] male; mean [SD] age, 43 [16] years) with 9057 (91.2%) followed up at 12 months. Mean PHQ-9 scores at 12 months for the high-risk cohort were lower in the intervention vs control groups (2.77 vs 4.48; mean difference, -1.71; 95% CI, -2.53 to -0.89; P < .001). The remission rate in the high-risk cohort (PHQ-9 and GAD-7 scores <5 and no risk of self-harm) was higher in the intervention vs control group (74.7% vs 50.6%; odds ratio [OR], 2.88; 95% CI, 1.53 to 5.42; P = .001). Across both cohorts, there was no difference in 12-month behavior scores in the intervention vs control group (17.39 vs 17.74; mean difference, -0.35; 95% CI, -1.11 to 0.41; P = .36). CONCLUSIONS AND RELEVANCE: A multifaceted intervention was effective in reducing depression risk but did not improve intended help-seeking behaviors for mental illness. TRIAL REGISTRATION: Clinical Trial Registry India: CTRI/2018/08/015355.
引用
- Maulik PK, Daniel M, Devarapalli S, et al. Mental Health Care Support in Rural India: A Cluster Randomized Clinical Trial. JAMA Psychiatry. 2024. PMID: 39141372. doi:10.1001/jamapsychiatry.2024.2305
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。